Bariatric surgery results in a clinically significant improvement in urinary incontinence. However, this is not proportional to pre-operative BMI, weight loss, age, parity and mode of delivery.

Purpose: Conventional Laparoscopic Cholecystectomy (CLC) is the "gold standard" approach for patients with gallstones. Single-incision Laparoscopic Cholecystectomy (SILC) was an alternative technique, purportedly offering several postoperative benefi ts over CLC. Studies comparing short-term postoperative outcomes of SILC versus CLC have yielded confl icting results. Our paper aims to compare the long-term postoperative outcomes of patients undergoing SILC and CLC with a minimum follow up of seven years. Methods: A comparative retrospective study between SILC and CLC was conducted among 118 patients undergoing cholecystectomy from October 2008 to December 2010 (SILC=67/CLC=61). An initial retrospective chart review was performed. We later surveyed the patients who had undergone cholecystectomy by telephone interview at a mean(sd) of 4(0.75) years, and at 8(0.75) years. Postoperative outcomes were evaluated. Results: No signifi cant difference between SILC and CLC groups for daily pain scores (p = 0.45 and 0.97, for day 1 and 2, respectively), daily narcotic requirements (p = 0.09 and 0.85, for day 1 and 2, respectively), and time to return to normal activity (p = 0.11). The mean(sd) operative time was greater in SILC group [52(2.0) mins versus 36(2.3) mins; p <0.05]. There was a shorter mean(sd) length of stay postoperatively in the SILC group [2(0.11) days versus 3(0.32) days; p <0.05]. The SILC group had a higher median(sd) cosmetic satisfaction score (IQR) than the CLC group at both the intermediate-term [10(10) versus 9(8 to10); p <0.05] and long-term [10(10) versus 9(9to10); p <0.05] follow up. Conclusion: SILC is associated with higher patient cosmetic satisfaction than CLC. However, the procedure is more technically challenging and associated with increased operating time and costs. The marginal cosmetic benefi t at the expense of increased operative time and economic costs will likely mean that the choice of procedure will be largely patient rather than physician driven.

No abstract

Introduction Although morbid obesity is strongly associated with cardiovascular disease (CVD) risk, relatively little research has been performed to evaluate the long-term effect of bariatric surgery (BS) on CVD risk reduction. Purpose To evaluate the 2-year effects of laparoscopic gastric bypass (LGBYP) & laparoscopic sleeve gastrectomy (LSG) on blood pressure, lipid profile, diabetic profile and Framingham risk score (FRS). Methods It was a retrospective review of patients undergoing BS between January 2009–2017. Body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), lipid & diabetic profile were recorded preoperatively & 2-year postoperatively. Results Of 416 patients, 77% (320) were females, 88% (365) were non-smokers & mean (sd) age was 48 (11) years. 69% (286) underwent LGBYP. 27% (114) were diabetic, 78% (324) were hyperlipidaemic and 65% (269) were hypertensive. The mean SBP & DBP decreased progressively while mean high-density-lipoprotein (HDL) & total-cholesterol (TC) increased progressively (table 1). LGBYP has a greater reduction in DBP than LSG (p&lt;0.001, t-test). 10-year CVD risk reduced by 37% at 2-year, with a greater effect in LGBYP than LSG (40% vs 28%, p&lt;0.001, t-test). Conclusion The 10-year risk of CVD reduced by 37% 2-years after bariatric surgery, with a greater risk reduction in LGBYP compared to LSG. Funding Acknowledgement Type of funding source: None

No abstract